Benzyl-activated Streptavidin Magnetic Beads

2026-09-20

Benzyl-activated Streptavidin Magnetic Beads (SKU: K1301) provide magnetic capture of biotinylated proteins, peptides, antibodies, sugars, oligonucleotides, and nucleic acids from complex samples. They are appropriate for purification, immunoprecipitation, and interaction workflows, but should not be treated as a universal capture reagent for non-biotinylated targets or as evidence of validated performance in a specific biological assay.

gamma-Glu-Cys: Assays, Peptide Synthesis & Plant Stress

2026-09-19

Use gamma-Glu-Cys as a defined substrate for glutathione synthetase enzyme assay development, peptide engineering, and cell-free plant stress studies. Its high solubility, characterized purity, and short-term solution handling requirements support reproducible experiments, while Bacillus research shows why strain and medium must be tested together.

PRC2 Inhibition Unlocks Chimpanzee Naive PSC Self-Renewal

2026-09-18

Huang et al. show that excessive PRC2-mediated H3K27me3 deposition is a barrier to sustained self-renewal of chimpanzee naive pluripotent stem cells. PRC2 inhibition produces cells that resemble human naive PSCs and early epiblast, retain broad developmental competence, and generate tri-lineage blastoids, while also improving feeder-free propagation of human naive PSCs.

ALC-0315 LNP Workflow for mRNA Delivery

2026-09-18

ALC-0315 provides a practical ionizable amino lipid foundation for screening mRNA lipid nanoparticles, from reporter assays to antigen-expression studies. This workflow pairs formulation controls with the staged validation strategy reported in a murine cryptococcosis vaccine study, while keeping exploratory parameters distinct from product specifications.

ECL Western Blotting Substrate: Workflow Guide

2026-09-17

ECL Western Blotting Substrate (SKU K2187) is a luminol-based, nonradioactive horseradish peroxidase detection reagent for generating chemiluminescent signals on immunoblots. It is intended for HRP-based Western blot assays using X-ray film or CCD imaging, not for fluorescent or radioisotopic detection formats.

BHQ: Rethinking SERCA-Driven HSC Mobilization

2026-09-17

2,5-di-tert-butylbenzene-1,4-diol (BHQ) is more than a calcium-store perturbant. By inhibiting SERCA, it connects calcium homeostasis disruption with mild ER stress and the CaMKII-STAT3-CXCR4 axis implicated in hematopoietic stem cell mobilization. This thought-leadership perspective examines the mechanistic evidence, experimental design, translational boundaries, and strategic opportunities for using BHQ in calcium signaling research.

CX-5461: From Pol I Stress to Translational Strategy

2026-09-16

CX-5461 is an RNA polymerase I inhibitor that converts dysregulated ribosome biogenesis into a measurable therapeutic vulnerability. This thought-leadership guide connects Pol I blockade with p53 signaling, DNA damage, mitotic catastrophe, autophagy, senescence, and cisplatin sensitization while outlining practical strategies for translational cancer research.

TPPU: Soluble Epoxide Hydrolase Workflows

2026-09-16

TPPU is a nanomolar soluble epoxide hydrolase inhibitor for connecting fatty acid epoxide signaling with inflammatory pain, redox biology, and osteoclast assays. This practical guide shows how to prepare, benchmark, and troubleshoot TPPU workflows while separating established evidence from emerging liver–bone applications.

ZAK Activation at the Collided Ribosome

2026-09-15

Huso and colleagues define how ribosome collisions activate the MAP3K ZAK through RACK1-dependent assembly and dimerization of ZAK SAM domains at the collision interface. By combining cryo-electron microscopy with biochemical and mutational analyses, the study distinguishes constitutive ribosome recruitment from collision-triggered activation and identifies SERBP1 as a negative regulator.

Carbapenemase Gene Dynamics in CREC Across Guangdong

2026-09-15

Nilotinib (AMN-107) in Kinase Signaling Workflows

2026-09-14

Nilotinib (AMN-107) gives researchers a selective, experimentally tractable way to perturb BCR-ABL, mutant KIT, and PDGFR signaling in cancer models. Its value extends beyond endpoint viability assays: paired with time-resolved phosphoproteomics and ribotoxic-stress analysis, it helps separate kinase-dependent phenotypes from broader stress responses.

Imatinib in Gastric Cancer Assembloid Research

2026-09-14

Imatinib (STI571) can reveal how tumor–stroma interactions reshape kinase-dependent drug responses. This article translates patient-derived gastric cancer assembloid findings into a rigorous framework for mechanism-aware signal transduction research.

Galectin-1, FIP200, and Hepatic Steatosis

2026-09-13

The 2026 reference study identifies a Galectin-1–FIP200 interaction as an upstream mechanism linking metabolic stress to autophagy blockade, hepatic steatosis, dyslipidemia, and insulin resistance. Its combination of animal phenotyping, proteomics, interaction mapping, binding analysis, and interface-disrupting mutations provides a mechanistic framework for studying autophagy control in NAFLD.

Cyclosporin A Workflows for Mechanistic Research

2026-09-12

Cyclosporin A supports distinct workflows for calcineurin–NF-AT signaling, mitochondrial permeability transition, and mechanistic immunosuppression. This guide shows how to use it as a pathway probe, how to separate cyclophilin-dependent effects from general toxicity, and how to apply it cautiously alongside the NMDA–Cav2.1 findings in cortical interneuron research.

1-phenyl-1H-pyrazolo[3,4-d]pyrimidin-4-amine Workflow

2026-09-11

Use PP 3 as a matched negative control to separate Src-dependent effects from vehicle, scaffold, and pathway artifacts in kinase and vascular assays. Its greatest value appears in workflows connecting Src kinase signaling pathway research with NADPH oxidase-derived ROS and L-type calcium-channel responses.